RELY (NASDAQ: RELY) files Form 144 reporting option exercise and 10b5-1 sales

Rhea-AI Filing Summary

RELY submitted a Form 144 notice reporting proposed and recent sales of common stock tied to option exercises and pre-arranged 10b5-1 plans. The filing lists a proposed sale of 10,000 shares via exercise on 04/17/2026 and prior 10b5-1 dispositions on 04/01/2026, 02/19/2026, and 02/11/2026 with associated cash amounts.

Key Figures

Proposed sale (exercise): 10,000 shares 10b5-1 sale proceeds (04/01/2026): $152,591.25 10b5-1 sale proceeds (02/19/2026): $49,050.00 +2 more

5 metrics

Proposed sale (exercise) 10,000 shares Exercise of Stock Options on 04/17/2026

10b5-1 sale proceeds (04/01/2026) $152,591.25 10,000 shares sold under 10b5-1 on 04/01/2026

10b5-1 sale proceeds (02/19/2026) $49,050.00 3,000 shares sold under 10b5-1 on 02/19/2026

10b5-1 sale proceeds (02/11/2026) $27,400.00 2,000 shares sold under 10b5-1 on 02/11/2026

Header cash figure $196,300.00 Amount shown in securities information row

Key Terms

10b5-1 Sales, Exercise of Stock Options, Issuer

3 terms

10b5-1 Sales regulatory

"10b5-1 Sales for PANKAJ SHARMA 401 Union Street"

Exercise of Stock Options financial

"Securities To Be Sold | 04/17/2026 | Exercise of Stock Options"

Issuer other

"Exercise of Stock Options | Issuer | 10000 | 04/17/2026"

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	10000	196300.00	210654386	04/17/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/17/2026	Exercise of Stock Options	Issuer			10000	04/17/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for PANKAJ SHARMA 401 Union Street, Suite 1000 SEATTLE WA 98101	Common	04/01/2026	10000	152591.25
10b5-1 Sales for PANKAJ SHARMA 401 Union Street, Suite 1000 SEATTLE WA 98101	Common	02/19/2026	3000	49050.00
10b5-1 Sales for PANKAJ SHARMA 401 Union Street, Suite 1000 SEATTLE WA 98101	Common	02/11/2026	2000	27400.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does RELY's Form 144 report show about recent insider sales?

It reports proposed and completed sales totaling multiple transactions. The filing lists a proposed 10,000-share exercise sale on 04/17/2026 and completed 10b5-1 sales of 10,000, 3,000, and 2,000 shares on the dates shown with cash amounts.

How many shares did RELY list for proposed sale on 04/17/2026?

The filing lists 10,000 shares proposed for sale on 04/17/2026. The entry is labeled an "Exercise of Stock Options" with the sale method shown as cash and the same date tied to the reported transaction.

What proceeds are reported for the completed 10b5-1 sales in the filing?

Several cash amounts are shown for completed sales. The filing lists $152,591.25 for 10,000 shares on 04/01/2026, $49,050.00 for 3,000 shares on 02/19/2026, and $27,400.00 for 2,000 shares on 02/11/2026.

Were the completed sales executed under a trading plan according to RELY's filing?

Yes — the filing identifies completed sales as 10b5-1 sales. Each completed disposition is labeled "10b5-1 Sales," indicating they were executed under pre-arranged trading plans on the dates shown in the filing.